 Hepatitis B, Chronic
"Hepatitis B, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Descriptor ID |
D019694
|
| MeSH Number(s) |
C02.256.430.400.100 C02.440.435.100 C06.552.380.350.100 C06.552.380.705.437.100
|
| Concept/Terms |
Hepatitis B, Chronic- Hepatitis B, Chronic
- Chronic Hepatitis B
- Hepatitis B Virus Infection, Chronic
- Chronic Hepatitis B Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B, Chronic".
This graph shows the total number of publications written about "Hepatitis B, Chronic" by people in this website by year, and whether "Hepatitis B, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2009 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2011 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2019 | 2 | 1 | 3 | | 2021 | 2 | 0 | 2 | | 2022 | 1 | 0 | 1 | | 2023 | 1 | 0 | 1 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B, Chronic" by people in Profiles.
-
Martin GE, Hosking K, Banz K, Gargan C, Stewart G, Greenwood-Smith B, Ramsay P, Tate-Baker J, Connors C, Binks P, McKinnon M, Manchikanti P, Gurruwiwi GG, Allard N, Qama A, Michaels J, Vintour-Cesar E, Batey R, Marshall C, Nihill P, Fernandes TA, Fuller K, Tong SYC, Boettiger D, Cowie B, Davis JS, Bukulatjpi SM, Davies J. Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, Australia. BMC Infect Dis. 2025 Jul 01; 25(1):881.
-
Winkler F, Hipp AV, Ramirez C, Martin B, Villa M, Neuwirt E, Gorka O, Aerssens J, Johansson SE, Rana N, Llewellyn-Lacey S, Price DA, Panning M, Groß O, Pearce EL, Hermann CM, Schumann K, Hannibal L, Neumann-Haefelin C, Boettler T, Knolle P, Hofmann M, Wohlleber D, Thimme R, Bengsch B. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells. Gut. 2023 10; 72(10):1971-1984.
-
Thomas DL, Kiser JJ, Baum MM. Long-Acting Treatments for Hepatitis B. Clin Infect Dis. 2022 11 21; 75(Suppl 4):S517-S524.
-
Zamor PJ, Lane AM. Interpretation of HBV Serologies. Clin Liver Dis. 2021 11; 25(4):689-709.
-
Aksakal M, Oktar SO, Sendur HN, Esendagli G, Ozenirler S, Cindoruk M, Hizel K. Diagnostic performance of 2D shear wave elastography in predicting liver fibrosis in patients with chronic hepatitis B and C: a histopathological correlation study. Abdom Radiol (NY). 2021 07; 46(7):3238-3244.
-
Smolders EJ, Burger DM, Feld JJ, Kiser JJ. Review article: clinical pharmacology of current and investigational hepatitis B virus therapies. Aliment Pharmacol Ther. 2020 01; 51(2):231-243.
-
Wyles DL. Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease. Clin Liver Dis. 2019 08; 23(3):473-486.
-
Luetkemeyer AF, Wyles DL. CROI 2019: highlights of viral hepatitis. Top Antivir Med. 2019 Apr; 27(1):41-49.
-
Williams R, Alexander G, Aspinall R, Batterham R, Bhala N, Bosanquet N, Severi K, Burton A, Burton R, Cramp ME, Day N, Dhawan A, Dillon J, Drummond C, Dyson J, Ferguson J, Foster GR, Gilmore I, Greenberg J, Henn C, Hudson M, Jarvis H, Kelly D, Mann J, McDougall N, McKee M, Moriarty K, Morling J, Newsome P, O'Grady J, Rolfe L, Rice P, Rutter H, Sheron N, Thorburn D, Verne J, Vohra J, Wass J, Yeoman A. Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2018 12 01; 392(10162):2398-2412.
-
Wang C, Chen V, Vu V, Le A, Nguyen L, Zhao C, Wong CR, Nguyen N, Li J, Zhang J, Trinh H, Nguyen MH. Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine (Baltimore). 2016 Aug; 95(35):e4744.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|